Search

Your search keyword '"Shimelis, Hermela"' showing total 160 results

Search Constraints

Start Over You searched for: Author "Shimelis, Hermela" Remove constraint Author: "Shimelis, Hermela"
160 results on '"Shimelis, Hermela"'

Search Results

2. Clinical validity assessment of genes frequently tested on intellectual disability/autism sequencing panels

3. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

4. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.

5. Pathogenic variants in autism gene KATNAL2 cause hydrocephalus and disrupt neuronal connectivity by impairing ciliary microtubule dynamics.

7. De novo Variants Disrupt an LDB1-Regulated Transcriptional Network in Congenital Ventriculomegaly

10. A novel SMARCC1 BAFopathy implicates neural progenitor epigenetic dysregulation in human hydrocephalus

12. Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

13. Data from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

15. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

16. Supplementary Tables and References from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

17. Data from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

18. Supplementary Figures from BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

19. A novel SMARCC1-mutant BAFopathy implicates epigenetic dysregulation of neural progenitors in hydrocephalus

20. Dual impact of PTEN mutation on CSF dynamics and cortical networks via the dysregulation of neural precursors and their interneuron descendants

24. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

25. CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival

29. CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival

36. Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer

37. The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort

38. Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.

39. Racial and ethnic differences in the results of multigene panel testing of inherited cancer predisposition genes in breast cancer patients.

40. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

41. Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes

42. BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study

43. Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing

44. Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands’ Susceptibility Gene Mutation Status

45. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer

47. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Catalog

Books, media, physical & digital resources